Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 09-2010 | 09-2009 | 09-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,867 | -8,174 | -8,522 | -5,372 | N/A |
| Depreciation Amortization | 4,210 | 345 | 1,387 | 6 | 20 |
| Accounts receivable | 8 | 0 | 14 | -39 | N/A |
| Other Working Capital | 715 | 95 | 985 | 637 | -80 |
| Other Operating Activity | 368 | 2,824 | 1,522 | 1,110 | 410 |
| Operating Cash Flow | $-3,566 | $-4,911 | $-4,614 | $-3,657 | $350 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | -15 | -2 | -31 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -44 | 0 |
| Investing Cash Flow | $-22 | $-15 | $-2 | $-75 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,235 | 1,100 | 1,700 | N/A | N/A |
| Debt Repayment | -16 | -96 | -181 | -62 | N/A |
| Common Stock Issued | N/A | 2,995 | 2,088 | N/A | N/A |
| Financing Cash Flow | $4,219 | $3,999 | $3,607 | $-62 | $N/A |
| Beginning Cash Position | 55 | 988 | 1,997 | 5,790 | N/A |
| End Cash Position | 74 | 62 | 988 | 1,997 | N/A |
| Net Cash Flow | $18 | $-926 | $-1,009 | $-3,793 | $350 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,566 | -4,911 | -4,614 | -3,657 | 350 |
| Capital Expenditure | -22 | -15 | -2 | -31 | N/A |
| Free Cash Flow | -3,587 | -4,926 | -4,616 | -3,688 | 350 |